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Abstract
From 1999–2014, obesity prevalence increased among adults and youth. Obese individuals may be 
uniquely susceptible to the proinflammatory effects of ozone because obese humans and animals 
have been shown to experience a greater decline in lung function than normal-weight subjects. 
Obesity is independently associated with limitations in lung mechanics with increased ozone dose. 
However, few epidemiologic studies have examined the interaction between excess weight and 
ozone exposure among adults. Using PubMed keyword searches and reference lists, we reviewed 
epidemiologic evidence to identify potential response-modifying factors and determine if obese or 
overweight adults are at increased risk of ozone-related health effects. We initially identified 170 
studies, of which seven studies met the criteria of examining the interaction of excess weight and 
ozone exposure on cardiopulmonary outcomes in adults, including four short-term ozone exposure 
studies in controlled laboratory settings and three community epidemiologic studies. In the studies 
identified, obesity was associated with decreased lung function and increased inflammatory 
mediators. Results were inconclusive about the effect modification when data were stratified by 
sex. Obese and overweight populations should be considered as candidate at-risk groups for 
epidemiologic studies of cardiopulmonary health related to air pollution exposures. Air pollution 
is a modifiable risk factor that may decrease lung function among obese individuals with 
implications for environmental and occupational health policy.
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Graphical abstract
INTRODUCTION
Obesity prevalence has been on the rise among adults in the U.S. (Figure 1). Approximately 
two-thirds of the U.S. adult population were overweight or obese in 2010.1 The study of 
community air pollution and ozone exposures has not accounted for the rise in obesity 
prevalence. Scientific investigations of the respiratory effects of obesity spanning the past 40 
years have reported that obesity and overweight conditions have a direct negative effect on 
respiratory well-being in addition to cardiovascular health, and these changes could have a 
direct effect on received dose and response to ozone (Figure 2).2–7 Understanding the effect 
of ozone exposures among adults with excess weight is important because the obesity 
problem is spreading around the globe with high calorie diets, sedentary lifestyles, and aging 
populations at a time when air pollution is increasingly adding to the global burden of 
disease.8
Most ozone exposure studies, however, do not account for how the increased prevalence of 
obesity or overweight status modifies the relationship between air pollution and 
cardiopulmonary health in the general population. Time series epidemiologic methods that 
examine death certificates or hospital admissions data do not provide direct information on 
patients’ weight and other anthropometric measures. Previous controlled ozone exposure 
laboratory, panel, and cohort studies do not reflect today’s increased prevalence of obesity. 
The National Institute of Health (NIH) defines obese a body mass index (BMI) of 30 kg/m2 
or greater and overweight as adults with a BMI of 25–29.9 kg/m2.9 According to NHANES 
data, in 2013–2014, the age-adjusted prevalence of obesity in the U.S. was 37.7% (95% CI, 
35.8%, 39.7%); among men, obesity prevalence was 35.0% (95% CI, 32.8%, 37.3%); and 
among women, it was 40.4% (95% CI, 37.6%, 43.3%).10
Ozone exposure has long been shown to reduce air flow and volume on a short-term basis 
(e.g., as measured by forced expiratory volume in one second (FEV1)) in mainly normal 
weight healthy adults.11,12 Epidemiologic studies have shown that chronic reduction in 
FEV1 is a powerful marker of future morbidity and cardiovascular mortality in the general 
population.13,14 Ozone exposures are associated with increased respiratory hospitalizations 
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and mortality.15–19 Accordingly, the U.S. Environmental Protection Agency (EPA) has 
judged the relationships between short-term (e.g., hours, days, weeks) exposure to ozone and 
respiratory morbidity to be causal.11 Moreover, EPA has judged the relationship between 
long-term (e.g., months to years) ozone exposures and respiratory effects, cardiovascular 
disease, central nervous system effects, and total mortality as “likely causal.”11 In the EPA’s 
2015 review of the science related to the national ambient air quality standards for ozone, 
EPA designated at-risk populations for these effects as shown in Table 1 (80 Federal 
Register 65291, October 26, 2015).
EPA’s 2015 review of at-risk populations considered ozone exposure studies from 2006 to 
July 2012 from the perspective of the Clean Air Act.20 Although EPA’s approach to at-risk 
populations characterized the available air pollution studies, the review did not consider 
other relevant biomedical evidence about the effects of obesity or overweight status from a 
population health perspective or the pulmonary health of overweight and obese groups, as 
summarized in Table 2. Moreover, evidence from animal models suggests that obese 
individuals may be susceptible to proinflammatory and oxidative stress injury of air 
pollution.21,22
Independently from air pollution exposure effects, pulmonary function is known to decline 
with increased abdominal adiposity or BMI, which may increase susceptibility to ozone-
related effects.5,23–25 In the U.S., adults generally gain weight as they age, which may 
predispose them for worse outcomes from air pollution exposures than seen in previous 
epidemiologic studies.5 The increased mass of the chest wall in obese individuals reduces 
compliance and respiratory muscle endurance, which increases the work of breathing.26,27 
Obese and overweight adults with increased abdominal fat mass may have less functional 
residual capacity than healthy-weight adults.5 Reduced lung volume contributes to closure of 
gas exchange units and ventilation-perfusion mismatching resulting in arterial hypoxemia 
and trapping of CO2.3,28,29 These abnormalities contribute to inflammation, the 
pathogenesis of asthma, obstructive sleep apnea, and other respiratory diseases.6,30–32 
Although there are obese individuals with healthy lung function, the literature documenting 
the respiratory status of obese and overweight populations suggests they are compromised 
compared to normal-weight adults, and as a result, obese people may experience a chronic 
inflammatory state.
Furthermore, experiments in animal models have shown that the pulmonary inflammatory 
response elicited by ozone exposure is enhanced in obese animals, which suggests that obese 
humans compared to nonobese individuals may be at risk of more adverse effects of air 
pollution.21,33–37 Enhanced pulmonary inflammation and injury have been shown with 
short-term ozone exposure in genetic and diet-induced obese mice.21,33–35,37–41 Higher 
levels of proinflammatory cytokines and chemokines (IL-6, CXCL1, MIP-2, MCP-1) have 
also been observed in obese animals following ozone exposure.21 Additional studies have 
investigated the role of diet and sedentary behavior on ozone exposure responses.42,43
A similar enhanced inflammatory response has been observed in obese human populations 
following ozone exposure. This response may augment bronchoconstriction, airway 
hyperreactivity, and mucus secretion, reducing the patency of conducting airways.44 
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Additionally, obese people may possess a greater number of peripheral blood leukocytes, 
which are known to contribute to pulmonary inflammation following exposure to ozone.45 
Proinflammatory mediators may be produced locally in the lung or may accumulate in the 
lung with the leakage of plasma fluid following disruption of the alveolar epithelium.44 
Higher levels of proinflammatory cytokines and adipokines have also been reported in the 
serum of obese subjects, which might contribute to greater airway inflammation.46,47
One of the underlying pathologies of obesity has been hypothesized to be linked to a chronic 
state of oxidative stress and impaired oxidant defense.48 Ozone mediates some of its adverse 
effects through oxidative stress; thus, antioxidant nutritional status may affect the risk of 
ozone-related health effects.49 In addition, individuals with reduced dietary intake of 
vitamins E and C are at increased risk for ozone-related health effects.20 Thus, poor diets 
associated with obesity might also be a factor.
Other air pollution literature about particulate matter exposures have highlighted enhanced 
responsiveness to cardiac end points with excess weight.50 Finally, emerging evidence 
suggests that improvements in particulate matter air pollution do not offer corresponding 
improvements for obese adults’ lung function.51
For all these reasons, we hypothesized that people with excess weight would be more 
reactive to the same ambient concentration of ozone. To test our hypothesis, we reviewed the 
epidemiological literature to identify potential response-modifying factors to determine if 
obese adults are at increased or decreased risk of health effects from ozone exposures. We 
also examined differences by sex in these associations.
MATERIALS AND METHODS
To identify epidemiology studies addressing the interaction between air pollution and 
obesity/overweight status on respiratory system effects, keyword and reference lists searches 
using PubMed were conducted using keywords, medical headings, and medical subject 
headings from three groups connected with “AND”:
1. air pollution or air pollutants, adverse effects and
2. obesity, body mass index, adiposity and
3. lung function tests; lung, drug effects; lung, growth, and development.
Conducted on December 1, 2015 and updated on August 29, 2016 and March 14, 2017, the 
search was restricted to studies published in English in the past 10 years and where the study 
subjects were adults. We searched for studies published since 2006 to be consistent with the 
2015 EPA national ambient air quality standards review and integrated science assessment.
This search initially identified 170 studies; abstracts were reviewed for ozone exposure 
among adults and a cardiopulmonary outcome. Studies within the past 10 years were then 
examined for information about the effect of both weight and ozone exposure among adults 
regarding a cardiopulmonary function. We excluded studies which controlled for BMI or 
other measures of obesity as an independent predictor of lung function but did not evaluate 
an interaction between excess weight and ozone. Physiological and biomedical studies of 
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obese adults and ozone exposure studies in humans and animal models were reviewed for 
factors related to obese and overweight status that may modify the relationship between both 
short-term and long-term ozone exposure and health effects.
RESULTS
Of the 170 studies identified, four studies were excluded because the subjects were 
children,52–56 and 159 were excluded because they did not examine the interaction of 
obesity and air pollution. Many excluded studies examined BMI as a covariate but did not 
analyze the interaction of BMI and ozone exposure. As shown in Table 3, seven studies met 
the criteria of examining the interaction of excess weight and ozone exposure on health 
outcomes in adults.57–63 They can be divided into controlled ozone exposure human studies 
in laboratories and community studies. Two of the community cross-sectional studies 
examined cardiovascular end points in the same Chinese study population.61,63
All studies used BMI as a quantitative measure of obesity, and one included waist 
circumference as a secondary selection criterion, and measured percent body fat by 
bioelectric impedance analysis although these measures were not analyzed further.58 The 
controlled human studies generally reported a positive interaction between obesity and 
ozone exposure with increasing FEV1 responsiveness, with the exception of one 
retrospective analysis of 40 adults reporting no interaction.64 The one longitudinal cohort 
study among older men reported a greater decline in lung function among the obese group.57
Most studies reported p-values for effect modification across strata, with one study reporting 
a three-way interaction trend test among ozone, obesity, and airway hyper-responsiveness.57 
The community epidemiologic studies used a variety of ozone exposure metrics including 
short-term and long-term exposure metrics. In the Boston study, a mean of ozone 
measurements 48 h prior to the exam, averaged across four local monitors using EPA 
protocols was selected after an assessment of averages of measurements on 1–5 days prior to 
exam.57 In the long-term exposure studies in China, researchers used the 3-year annual 
average ozone (removing outliers) from a central monitor within 1 km of participants’ 
homes in 33 northeastern Chinese cities. Compared to U.S. ambient levels, the Chinese 
study assessed significantly higher ozone concentrations: the Chinese 3-year mean was 
1.2589 ppm (SD 0.35856) compared to Boston’s 48 h average of 0.0244 ppm (SD 0.011). 
As a point of reference, the U.S. EPA set the 2015 national ambient air quality standards for 
ozone at 0.070 ppm maximum 8 h average (80 Federal Register 65291, October 26, 2015).
DISCUSSION
Weight gain has been shown to reduce lung function in healthy overweight and obese 
adults.28 In a cohort study of healthy subjects, the quartile who gained the most weight over 
10 years compared to the lowest quartile had the largest decrease in forced vital capacity 
(FVC) and FEV1.5 Thus, increased obesity prevalence contributes to the poor respiratory 
health of the general adult population. The altered physiological and proinflammatory states 
typical of obese populations may place an additional burden on their cardiac and respiratory 
systems from air pollution exposure. Experimental evidence from animal models also 
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supports that obesity modifies the association between ozone exposure and cardiorespiratory 
health via inflammation34 and oxidative stress.22
Evaluating pulmonary susceptibility is complicated, however, because obesity is a complex 
metabolic condition that influences many systems and results in a variety of comorbidities 
(e.g., hypertension, asthma) that may also affect respiratory health. In the seven human 
subject studies identified, increased BMI was associated with ozone-related decreased lung 
function and increased inflammatory mediators. Controlled ozone exposure studies in 
human subjects provided the strongest evidence that the ozone-induced decrement in lung 
function is greater in the obese group compared to normal weight participants.58,60 Results 
from a longitudinal cohort study supported this finding; however, the subjects were mainly 
older white males.57 In the larger Chinese cross-sectional studies, greater positive 
associations with cardiovascular outcomes were reported for obese than normal-weight 
participants for long-term relatively higher ozone concentrations (mean 3-year average 
ozone level of 1.26 ppm).
There is evidence that obese populations receive an increased dose of ozone for the same 
ambient concentration (Table 2). In controlled air pollution exposure studies among human 
subjects, researchers can control the dose. In the four studies identified in this review, 
researchers assigned exposures to known doses of ozone in laboratory-controlled settings 
among generally healthy nonsmoking adult volunteers. Researchers administered known 
concentrations of ozone via chamber or facemask exposures and used exercise and body 
surface area to calculate and control target ventilation. This controlled exposure study design 
allowed for direct causal inference, control over confounding by copollutants, and 
assignment of the received dose of ozone to construct dose–response curves. The 
investigators collected detailed anthropomorphic information, such as body weight and 
percent body fat measurements, controlled for age, asthma status, smoking, and sex, and 
used a relatively large sample size. In general, for the ozone-induced effect, subjects served 
as their own control; investigators compared outcomes with the ozone dose to outcomes with 
a filtered air exposure. A further advantage was that the lung function measurements were 
well documented using standardized, reproducible techniques.
While significant insights were gained from controlled human exposure studies, three of the 
studies were not originally designed to evaluate the potential effect modification by obesity. 
Thus, few obese subjects were included, and the analysis of effect modification by BMI was 
typically conducted as a secondary analysis. As a result, BMI may more appropriately be 
interpreted as differences in body size among normal individuals rather than the effect of 
obesity on the relationship between ozone dose and lung function. A notable exception was 
the Bennett et al. 2016 study, which was designed to examine the effect of obesity on ozone 
exposure effects among healthy nonsmoking women with 0.4 ppm short-term ozone 
exposures. Future research should consider the detection of effect modification by obesity 
and overweight status of the ozone dose–response relationship over a wider range of 
concentrations, averaging times, and types of subjects.
While there are significant advantages to controlling ozone exposure in a laboratory setting, 
the pattern may deviate significantly from ambient exposure patterns. Another limitation is 
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that chamber study subjects differ from the general population and are generally healthier, 
younger, and nonsmoking. Thus, insights from community epidemiologic studies augment 
these inherent limitations. In community studies, fuller ozone exposure patterns are 
evaluated among larger populations including a broader spectrum of health, lung function, 
and disease status. Community studies are especially important in studying ozone exposures 
because of the heterogeneous responses to ozone including presence of weak responders and 
smaller response among those older than 35 years.65 Strengths of the Normative Aging 
Study included its study design, long follow-up period, well-characterized spirometry 
outcomes, control of known confounders, and the quality of the short-term ozone 
measurements.57 Strengths of the Chinese studies included the large sample size with 
significant numbers of overweight (n = 8 764) and obese (n = 1 435) participants with a 
broad age and air pollution range.54,63 Limitations of the Chinese studies included lack of 
temporality between the exposure and outcome; ozone exposure misclassification; selection 
bias (e.g., healthy subjects were more likely to participate); and information bias (e.g., recall 
bias and self-reported end point, the use of prevalence rather than incidence of 
hypertension). Because of a moderate correlation between ambient ozone and particulate 
matter concentrations in the study districts, there may also be confounding by particulate 
matter, which is more strongly associated with cardiovascular outcomes.50
In general, few studies examined the interaction of excess weight and ozone exposure. The 
studies generally reported greater lung function decrements associated with ozone at 
increased weight categories. However, the results were inconclusive about effect 
modification when data were stratified by sex; these results are consistent with primary 
evidence (not examining the interaction with excess weight) about potential differences by 
sex in ozone exposure epidemiologic studies of respiratory hospital admissions.66,67 In 
general, after multiple exposures over a period of days, individuals have lower responses to 
ozone.68–70 However, young women lose ozone-responsiveness with multiple exposures to 
ozone three-times faster than young men, although in middle age, men and women lose 
responsiveness at the same rates.65 In addition, Vancza et al. reported small strain-dependent 
differences in effects by sex in adult mice with respect to pulmonary inflammation and 
injury after ozone exposure, with adult females generally more at risk. Lactating female 
mice incurred the greatest lung injury and inflammation among several strains of mice.71 
However, some toxicological studies found some strains exhibiting greater risk in males. 
Thus, although experimental studies have provided potential biological plausibility for 
potential sex differences for the effect of ozone exposure on lung function, the results of 
these limited number of studies are inconclusive.
While the absence of a formal meta-analysis of the epidemiologic studies may be viewed as 
a limitation of this review, too many differing study designs and too few studies were 
identified to facilitate meaningful pooling of effect. However, the McDonnell et al. study 
provides a set of equations for researchers to test new controlled human subject data as they 
become available.60
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CONCLUSION
The pulmonary inflammatory response elicited by ozone is enhanced in obese animals, 
which suggests that obese humans may be at increased risk of adverse effects of air 
pollution. Because obese and overweight populations exhibit limitations in pulmonary 
function and receive a greater dose of ambient pollution, the extent to which exposure to 
ozone induces adverse effects should be directly evaluated in additional studies. However, 
the current evidence generally supports a positive effect of excess weight on the relationship 
between ozone and lung function. There is a suggestion of a positive interaction for cardiac 
end points; however, the results by sex are inconclusive in cross-sectional studies. If 
confirmed, an interaction between excess weight and enhanced ozone response may provide 
public health advocates and clinicians with additional reason to promote the maintenance of 
a healthy body weight and diet.
The World Health Organization estimated that approximately 2.3 billion adults worldwide in 
2015 were overweight.32 As obesity prevalence increases, there is increasing uncertainty as 
to how well the principal studies used to calculate end points in risk assessment, economic 
benefit assessment, or burden of disease calculations represent the impacts with respect to 
obese or overweight adult and elderly populations. In addition, while further evidence is 
required, recognition of this susceptibility could help regulators to designate obese 
populations as at-risk populations under the Clean Air Act for consideration in standard 
setting and public health warnings for air pollution.
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ABBREVIATIONS
BMI body mass index
CVD cardiovascular disease
DBP diastolic blood pressure
FEV1 forced expiratory volume in one second
FVC forced vital capacity
FEF25–75% forced expiratory flow at 25–75% of FVC
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IL interleukin
PMN polymorphonuclear
Eos eosinophils
SBP systolic blood pressure
TNF-α tumor necrosis factor alpha
EPA U.S. Environmental Protection Agency
μg/m3 micrograms per cubic meter
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Figure 1. 
Obesity prevalence among adults has increased since the early 2000s in the U.S. based on 
Behavioral Risk Factor Surveillance System data.72
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Figure 2. 
Overview of ozone exposure and obesity on inflammation and oxidative stress in the lung. 
When the respiratory system is challenged by ozone (O3), particulate matter (PM), allergens, 
or bacteria, cytokines generated in the lungs (TNF-α, IL-1β, and IL-6), and LPS from 
disseminated bacteria can enhance the production of proinflammatory mediators released 
systemically by adipose tissue. The augmentation of systemic inflammation in the obese can 
enhance pulmonary inflammatory responses by enhancing leukocyte recruitment, cytokine 
production, microvascular permeability, and edema, which could potentially increase airway 
obstruction in preexisting lung disease.44
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Table 1
U.S. Environmental Protection Agency’s Designated At-Risk Populations for Ozone Air Pollution (2015)a
category of evidence population
adequate evidence asthmatics
children under 18 years
older adults at and above 65 years
populations with poor diets with nutritional (antioxidant or vitamin) deficiencies
outdoor workers
suggestive evidence obese populationsb
populations with genetic markers
women
populations of low socioeconomic status
inadequate evidence patients with the following:
chronic obstructive pulmonary disease
cardiovascular disease
diabetes
hyperthyroidism
influenza and other respiratory infections
racial groups
smokers
evidence of no effect
not assessed overweight populationsb
pregnant women
outdoor athletes
aNote: Data are adapted from U.S. Environmental Protection Agency Integrated Science Assessment for Ozone (2012), Section 8.5, Tables 8–4.11
bNIH defines obese a BMI of 30 kg/m2 or greater and overweight as adults with a BMI of 25–29.9 kg/m2.9
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Table 2
Summary of Evidence that Obese Populations are At-Risk for Ozone Exposurea
at-risk population criterion summary of evidence
(1) higher exposures not likely a factor
(2) higher dose for given ambient concentration BMI associated with graded increases in the estimated total lung dose of fine particulates in 
children73b
increased minute ventilation3,6,73
more work to maintain appropriate levels of circulating oxygen in their bloodstreams28,74
increased oxygen consumption3
stiffening of the chest wall and increasing the mechanical work of breathing3,4,6,28
airway closure and gas exchange deficiencies in obese populations3,29
dyspnea at rest in obese men75
obese individuals are less efficient and need to exert more due to the increased work of 
breathing and reduced cardiovascular fitness compared to normal weight people; the 
increased respiratory rate would increase the dose76
(3) more responsive to same dose among healthy nonsmoking women, enhanced FEV1 decrements following ozone exposure 
in the overweight/obese category (BMI ≥ 25) compared with the normal weight women 
although not in men59,65b
enhanced pulmonary inflammation and injury with short-term ozone exposure in 
genetically and dietarily obese mice21,33,34,77b
in healthy normal-weight adults, increased BMI associated with enhanced FEV1 responses 
to ozone60b
greater decline in FEV1 and FVC in the obese than in the nonobese white elderly men 
associated with short-term ozone exposure. Three-way interaction trend test demonstrated a 
multiplicative effect of airway hyper-responsiveness (AHR) and obesity factors57b
obese individuals may be uniquely susceptible to the proinflammatory effects of ozone 
since obese humans and animals have been shown to experience a greater decline in lung 
function than normal weight subjects21,35,39,57b
higher levels of proinflammatory cytokines and chemokines (IL-6, CXCL1 (KC), MIP-2, 
MCP-1) have been observed in obese animals following ozone exposure21b
increased responses to short-term ozone in obese db/db mice compared to wild-type 
controls37–39
evidence of effect modification for ozone exposures and cough and phlegm but not wheeze 
or asthma for annual ozone52
additional evidence of obese individuals’ susceptibility to proinflammatory effects of ozone 
since obese humans and animals have been shown to experience a greater decline in lung 
function than normal weight subjects35,39,44
obese may possess a greater number of peripheral blood leukocytes known to contribute to 
pulmonary inflammation following exposure to ozone45
proinflammatory mediators may be produced locally in the lung or may accumulate in the 
lung with the leakage of plasma fluid following disruption of the alveolar epithelium44
higher levels of proinflammatory cytokines and adipokines reported in the serum of obese 
subjects, which might contribute to greater airway inflammation35,78
elevations in systemic acute phase proteins such as C-reactive protein, known to be 
elevated in the obese following PM exposure, may also contribute to greater pulmonary 
inflammation78,79
suggestive evidence of lack of recovery of obese groups compared with normal weight 
groups from improvements in air pollution from PM exposures80
(4) population-based perspective: diminished 
pulmonary function
obesity and overweight conditions have direct negative effect on respiratory well-being in 
addition to cardiac health2–7,63
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at-risk population criterion summary of evidence
increased fat mass and increasing BMI reduces lung volumes and FEV181
weight gain reduces lung function in healthy overweight and obese adults5,28
subjects who gained the most weight over 10 years lost the most lung function5
in 8-year study of adults in which lung function changes (FVC, FEV1, and vital capacity) 
decreased with increasing BMI quartiles24
abdominal obesity was strongly associated with lung function impairment in study of more 
than 150 000 adults examining metabolic syndrome (a cluster of cardiovascular risk 
factors)82,83
inverse relationship between multiple measures of fatness with both spirometry and static 
lung volumes84
aAbbreviations: body mass index (BMI); forced expiratory volume in one second (FEV1); forced vital capacity (FVC); forced expiratory flow at 
25–75% of FVC (FEF25–75%); interleukin (IL); chemokine (C-X-C motif) ligand 1 (KC); polymorphonuclear (PMN); eosinophils (Eos); tumor 
necrosis factor alpha (TNF-α); U.S. Environmental Protection Agency (EPA).
b
Evidence considered by U.S. EPA Integrated Scientific Assessment for Ozone.11
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EV
1/F
V
C 
(p 
=
 0
.0
50
).
FE
F 2
5–
75
/F
V
C
A
 o
ne
 u
ni
t i
nc
re
as
e 
in
 B
M
I w
as
 
as
so
ci
at
ed
 w
ith
 a
 d
ec
re
as
e 
of
 0
.7
32
 
FE
F 2
5–
75
/F
V
C 
(p 
=
 0
.0
23
).
B
en
ne
tt 
et
 a
l. 
20
16
58
do
ub
le
 b
lin
de
d 
ra
nd
om
 c
ro
ss
ov
er
 
co
n
tr
ol
le
d 
hu
m
an
 ex
po
su
re
 st
ud
y 
ag
e,
 ra
ce
B
M
I a
nd
 w
ai
st 
ci
rc
um
fe
re
nc
e 
(W
C)
sh
or
t-t
er
m
: 
ex
po
se
d 
to
 0
.4
 
pp
m
 o
zo
ne
 fo
r 2
 h
 
%
ΔF
EV
1
O
zo
ne
-in
du
ce
d 
de
cr
em
en
ts 
in
 o
be
se
 
v
er
su
s 
n
o
rm
al
-w
ei
gh
t p
ar
tic
ip
an
ts 
n
o
t s
ig
ni
fic
an
t (
p 
=
 0
.1
1).
 M
ea
n 
Chem Res Toxicol. Author manuscript; available in PMC 2017 August 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Koman and Mancuso Page 20
st
ud
y 
an
d 
lo
ca
tio
n
st
ud
y 
de
sig
n 
an
d 
po
pu
la
tio
n
co
v
a
ri
at
es
o
be
sit
y 
m
ea
su
re
o
zo
n
e 
m
ea
su
re
o
u
tc
om
es
m
a
in
 fi
nd
in
gs
 e
ffe
ct
 e
st
im
at
es
 
(95
%
 C
l)
w
ith
 a
tte
m
pt
 to
 m
at
ch
 g
ro
up
 
co
m
po
sit
io
n 
by
 ra
ce
w
ith
 in
te
rm
itt
en
t 
ex
er
ci
se
 a
nd
 re
st 
de
sig
ne
d 
to
 
pr
od
uc
e 
a 
m
in
ut
e 
v
en
til
at
io
n 
of
 2
0–
30
 l/
m
in
 u
sin
g 
Li
fe
sh
irt
 v
es
t
%
ΔF
EV
1 
(S
D)
 am
on
g o
be
se 
15
.9 
(8.
6) 
an
d a
mo
ng
 no
rm
al-
we
igh
t 
gr
ou
p 
11
.7
 (7
.1)
.
N
or
th
 C
ar
ol
in
a 
(da
te 
no
t 
sp
ec
ifi
ed
)
38
 n
on
as
th
m
at
ic
 n
on
sm
ok
in
g 
yo
un
g 
w
o
m
en
 (a
ge
d 1
8–
35
 ye
ars
)
N
or
m
al
 (n
 
=
 1
9) 
de
fin
ed
 a
s B
M
I ≤
 
25
 k
g/
m
2  
an
d 
W
C 
≤ 
29
.5
 in
. O
be
se
 (n
 
=
 1
9) 
de
fin
ed
 a
s 
B
M
I r
an
ge
 3
0–
40
 
kg
/m
2  
an
d 
W
C 
≥ 
35
 in
.
%
ΔF
V
C
co
u
gh
 
fre
qu
en
cy
 a
nd
 
se
v
er
ity
m
et
ha
ch
ol
in
e 
re
ac
tiv
ity
,
 
in
sp
ira
to
ry
 
ca
pa
ci
ty
 (I
C)
, 
an
d 
sG
AW
 
(sp
ec
ifi
c 
ai
rw
ay
 
co
n
du
ct
an
ce
)
pl
as
m
a 
IL
-6
pl
as
m
a 
CR
P,
 
le
pt
in
, I
L-
1β
,
 
IL
-8
, T
N
F-
α
sp
ut
um
 P
M
N
sp
ut
um
 IL
-6
sp
ut
um
IL
-1
β, 
IL
-8
, T
N
F-
α
m
ea
n
 (S
D)
 am
on
g o
be
se 
12
.5 
(7.
5) 
an
d 
am
on
g 
no
rm
al
-w
ei
gh
t g
ro
up
 8
.0
 
(5.
8) 
(p 
<
 0
.0
5)
O
zo
ne
-in
du
ce
d 
co
ug
h 
fre
qu
en
cy
 
in
cr
ea
se
d 
am
on
g 
no
rm
al
 w
ei
gh
t (
p 
<
 
0.
01
) b
u
t n
ot
 a
m
on
g 
ob
es
e 
pa
rti
ci
pa
nt
s. 
M
ea
n 
(S
D)
 co
ug
h 
fre
qu
en
cy
 w
as
 lo
w
 a
n
d 
di
d 
no
t d
iff
er
 
be
tw
ee
n 
gr
ou
ps
: o
be
se
 2
.6
 (5
.4)
 (p
 
>
 
0.
05
) a
nd
 am
on
g n
orm
al-
we
igh
t 
gr
ou
p 
4.
9 
(6.
5).
O
zo
ne
-in
du
ce
d 
di
ffe
re
nc
es
 in
 o
be
se
 
v
er
su
s 
n
o
rm
al
-w
ei
gh
t p
ar
tic
ip
an
ts 
n
o
t s
ig
ni
fic
an
t.
M
ea
n 
IC
 a
m
on
g 
ob
es
e 
16
.7
 (1
4.2
) 
an
d 
am
on
g 
no
rm
al
-w
ei
gh
t g
ro
up
 
10
.2
 (1
3.2
) (
p 
=
 0
.1
2).
M
ea
n 
sG
AW
 a
m
on
g 
ob
es
e 
12
.6
 
(26
.2)
 an
d a
mo
ng
 no
rm
al 
we
igh
t 
gr
ou
p 
12
.4
 (2
1.0
), n
ot 
sig
nif
ic
an
t.
O
zo
ne
-in
du
ce
d 
pl
as
m
a 
IL
-6
 w
as
 
in
cr
ea
se
d 
in
 b
ot
h 
gr
ou
ps
 (p
 
<
 0
.0
05
) 
an
d 
m
or
e 
pr
on
ou
nc
ed
ly
 a
m
on
g 
o
be
se
 v
er
su
s 
n
o
rm
al
-w
ei
gh
t 
pa
rti
ci
pa
nt
s a
t 4
 h
 (p
 
in
te
ra
ct
io
n 
< 
0.
00
6) 
an
d r
etu
rne
d t
o n
orm
al 
at 
20
 
h. O
zo
ne
-in
du
ce
d 
ch
an
ge
s w
er
e 
no
t 
o
bs
er
ve
d 
in
 o
be
se
 o
r n
or
m
al
-w
ei
gh
t 
pa
rti
ci
pa
nt
s.
O
zo
ne
-in
du
ce
d 
in
cr
ea
se
s w
er
e 
no
t 
o
bs
er
ve
d 
in
 o
be
se
 o
r n
or
m
al
-w
ei
gh
t 
pa
rti
ci
pa
nt
s. 
So
m
e 
ev
id
en
ce
 o
f t
re
nd
 
am
o
n
g 
ob
es
e 
fo
r o
zo
ne
 v
er
su
s 
ai
r 
tr
ea
tm
en
t u
sin
g 
W
ilc
ox
on
 m
at
ch
ed
 
pa
irs
 si
gn
 ra
nk
 te
st 
(p 
=
 0
.1
1).
O
zo
ne
-in
du
ce
d 
in
cr
ea
se
s a
m
on
g 
n
o
rm
al
 w
ei
gh
t b
u
t n
ot
 a
m
on
g 
ob
es
e 
pa
rti
ci
pa
nt
s.
O
zo
ne
-in
du
ce
d 
in
cr
ea
se
s w
er
e 
no
t 
o
bs
er
ve
d 
in
 o
be
se
 o
r n
or
m
al
-w
ei
gh
t 
pa
rti
ci
pa
nt
s.
M
cD
on
ne
ll 
et
 a
l. 
20
09
60
N
or
th
 C
ar
ol
in
a 
an
d 
D
av
is,
 
CA
 (1
98
1–
19
92
)
m
et
a 
an
al
ys
is 
of
 1
5 
co
nt
ro
lle
d 
hu
m
an
 
ex
po
su
re
 st
ud
ie
s
54
1 
he
al
th
y 
no
rm
al
 w
ei
gh
t y
ou
ng
 
ad
ul
ts 
(ag
ed
 18
–3
5 y
ea
rs,
 90
 fe
ma
les
)
ag
e,
 st
ra
tif
ie
d 
by
 
o
zo
n
e 
ex
po
su
re
 
pa
tte
rn
B
M
I (
me
an
 23
.41
 
kg
/m
2 )
sh
or
t-t
er
m
: 
ex
po
su
re
s r
an
ge
d 
fro
m
 0
.0
4–
0.
12
 
pp
m
 fo
r 6
.6
 h
 w
ith
 
%
ΔF
EV
1
In
cr
ea
sin
g 
BM
I w
as
 a
ss
o
ci
at
ed
 w
ith
 
in
cr
ea
sin
g 
FE
V
1 
re
sp
on
siv
en
es
s 
(be
ta 
0.4
85
5 (
95
% 
CI
 0.
10
18
, 
0.
86
93
, p
-
v
al
ue
 0
.0
13
). I
nc
lus
ion
 of
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st
ud
y 
an
d 
lo
ca
tio
n
st
ud
y 
de
sig
n 
an
d 
po
pu
la
tio
n
co
v
a
ri
at
es
o
be
sit
y 
m
ea
su
re
o
zo
n
e 
m
ea
su
re
o
u
tc
om
es
m
a
in
 fi
nd
in
gs
 e
ffe
ct
 e
st
im
at
es
 
(95
%
 C
l)
Se
x
 w
as
 a
v
ai
la
bl
e 
bu
t 
n
o
t i
nc
lu
de
d 
in
 fi
na
l 
m
o
de
l.
in
te
rm
itt
en
t 
ex
er
ci
se
B
M
I i
n 
th
e 
m
od
el
 re
su
lte
d 
in
 
in
di
v
id
ua
l p
re
di
ct
ed
 v
al
ue
s w
ith
in
 
0.
3%
 o
f F
EV
1 
de
cr
em
en
t.
To
do
ric
 e
t a
l. 
20
14
62
re
tr
os
pe
ct
iv
e 
an
al
ys
is 
of
 ex
ist
in
g 
co
n
tr
ol
le
d 
hu
m
an
 tr
ia
l; 
Sp
ea
rm
an
 
co
rr
el
at
io
ns
; r
eg
re
ss
io
n 
an
al
ys
is
ag
e,
 e
th
ni
ci
ty
,
 
se
x
, 
as
th
m
a 
sta
tu
s
B
M
I (
14
 of
 40
 
su
bje
cts
 w
ere
 
o
v
er
w
ei
gh
t, 
BM
I ≥
 
25
 k
g/
m
2 ,
 
(m
ea
n 
24
.1
, r
an
ge
 2
1.
8–
27
.5
 k
g/
m
2 )
sh
or
t-t
er
m
: 0
.4
 
pp
m
, a
v
er
ag
in
g 
tim
e 
no
t l
ist
ed
%
 p
re
di
ct
ed
 
FE
V
1,
 
FV
C
n
o
 s
ig
ni
fic
an
t c
or
re
la
tio
n 
be
tw
ee
n 
B
M
I a
nd
 c
ha
ng
e 
in
 %
 p
re
di
ct
ed
 
FV
C 
or
 F
EV
1,
 
w
ith
 o
zo
ne
 ex
po
su
re
N
or
th
 C
ar
ol
in
a
40
 a
du
lts
 (3
1 h
ea
lth
y,
 
9 
w
ith
 al
le
rg
ic
 
as
th
m
a)
m
ea
su
re
m
en
ts
 
co
m
pa
re
d 
ba
se
lin
e 
ei
th
er
 2
 d
ay
s o
r 2
 
w
ee
ks
 b
ef
or
e 
co
n
tr
ol
le
d 
oz
on
e 
ex
po
su
re
 a
nd
 th
en
 
4 
h 
(sp
iro
me
try
,
 
sp
ut
nu
m
 a
nd
 
bl
oo
d) 
an
d 2
4 h
 
(fo
r s
pu
tnu
m 
an
d 
bl
oo
d)
de
lta
 IL
-1
β, 
de
lta
 IL
-6
, a
nd
 
de
lta
 IL
-8
de
lta
 IL
-lβ
sp
ut
nu
m
 
%
ΔP
M
N
se
ru
m
 %
ΔP
M
N
B
M
I w
as
 p
os
iti
v
el
y 
as
so
ci
at
ed
 w
ith
 
sp
ut
um
 IL
-1
β 2
4 
h 
af
te
r c
on
tro
lle
d 
o
zo
n
e 
ex
po
su
re
 (r
 
=
 0
.5
, p
 
=
 0
.0
04
) 
bu
t n
ot
 e
ith
er
 IL
-6
 o
r I
L-
8.
B
M
I w
as
 w
ea
kl
y 
co
rre
la
te
d 
w
ith
 
ch
an
ge
 in
 sp
ut
um
 IL
-1
β (
Sp
ea
rm
an
 
co
rr
el
at
io
n 
R 
=
 0
.4
, p
 
=
 0
.0
3) 
an
d i
n 
bl
oo
d 
(S
pe
arm
an
 co
rre
lat
ion
 R
 
=
 
0.
7,
 p
 
=
 0
.0
03
) a
fte
r 2
4 h
. A
 on
e u
nit
 
in
cr
ea
se
 in
 B
M
I w
as
 a
ss
o
ci
at
ed
 w
ith
 
20
 p
g/
m
L 
in
cr
ea
se
 in
 sp
ut
um
 IL
-1
β 
w
ith
 o
zo
ne
 ex
po
su
re
.
N
o 
co
rre
la
tio
n 
be
tw
ee
n 
BM
I a
nd
 
ch
an
ge
 in
 sp
ut
um
 %
 Δ
PM
N
 (p
 
=
 
0.
30
) o
r %
Eo
s (
p 
=
 0
.0
9) 
wi
th 
oz
on
e 
ex
po
su
re
.
Se
ru
m
 %
PM
N
s s
ig
ni
fic
an
tly
 
in
cr
ea
se
d 
(p 
<
 0
.0
1),
 an
d %
 E
os
 
de
cr
ea
se
d 
(p 
=
 0
.0
1) 
wi
th 
oz
on
e 
ex
po
su
re
.
Co
m
m
un
ity
 S
tu
di
es
A
le
x
ee
ff 
et
 a
l. 
20
07
57
lo
ng
itu
di
na
l c
oh
or
t s
tu
dy
ag
e,
 ra
ce
, s
m
ok
in
g 
st
at
us
, l
ife
tim
e 
sm
o
ki
ng
 p
ac
k 
ye
ar
s, 
ch
ro
ni
c 
di
se
as
es
, 
ai
rw
ay
 
hy
pe
rre
sp
on
siv
en
es
s 
(A
HR
)
B
M
I (
me
an
 27
.8,
 
SD
 3
.7
 k
g/
m
2 )
sh
or
t-t
er
m
: 2
-d
ay
 
m
ea
n
 (m
ea
n 2
4.4
, 
SD
 1
1.
0)
lu
ng
 fu
nc
tio
n
G
re
at
er
 d
ec
lin
es
 in
 %
ΔF
EV
1 
an
d 
%
ΔF
V
C 
ar
e 
ob
se
rv
ed
 in
 th
e 
ob
es
e 
th
an
 in
 th
e 
no
no
be
se
 w
hi
te
 e
ld
er
ly
 
m
en
 a
ss
o
ci
at
ed
 w
ith
 sh
or
t-t
er
m
 
o
zo
n
e 
ex
po
su
re
. T
hr
ee
-w
ay
 
in
te
ra
ct
io
n 
tre
nd
 te
st 
de
m
on
str
at
ed
 a
 
m
u
lti
pl
ic
at
iv
e 
ef
fe
ct
 o
f A
H
R 
an
d 
o
be
sit
y 
fa
ct
or
s.
G
re
at
er
 B
os
to
n 
ar
ea
 (1
99
5–
20
05
), V
et
er
an
s 
A
dm
in
ist
ra
tio
n 
N
or
m
at
iv
e 
A
gi
ng
 S
tu
dy
 c
oh
or
t
90
4 
el
de
rly
 m
ai
nl
y 
w
hi
te
 m
en
%
ΔF
EV
1
%
ΔF
V
C
Fo
r 
ea
ch
 1
5 
pp
b 
in
cr
ea
se
 in
 o
zo
ne
, 
o
be
se
 p
ar
tic
ip
an
ts 
ha
d 
a 
gr
ea
te
r 
de
cr
ea
se
 in
 %
ΔF
EV
1 
th
an
 n
on
ob
es
e 
(−
2.6
3%
 (−
3.8
5, 
−1
.39
) v
s −
1.1
5%
 
(−
1.9
1, 
−0
.39
), i
nte
rac
tio
n p
 
<
 0
.0
5).
Fo
r 
ea
ch
 1
5 
pp
b 
in
cr
ea
se
 in
 o
zo
ne
, 
o
be
se
 p
ar
tic
ip
an
ts 
ha
d 
a 
gr
ea
te
r 
de
cr
ea
se
 in
 %
ΔF
V
C 
th
an
 n
on
ob
es
e 
(−
2.0
5%
 (−
3.1
7, 
−0
.91
9) 
vs
. −
.
11
8%
 (−
1.8
8, 
−0
.48
), i
nte
rac
tio
n n
ot 
sig
ni
fic
an
t).
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st
ud
y 
an
d 
lo
ca
tio
n
st
ud
y 
de
sig
n 
an
d 
po
pu
la
tio
n
co
v
a
ri
at
es
o
be
sit
y 
m
ea
su
re
o
zo
n
e 
m
ea
su
re
o
u
tc
om
es
m
a
in
 fi
nd
in
gs
 e
ffe
ct
 e
st
im
at
es
 
(95
%
 C
l)
Zh
ao
 e
t a
l. 
20
13
63
33
 c
om
m
un
iti
es
 in
 th
re
e 
n
o
rt
he
as
te
rn
 C
hi
ne
se
 c
iti
es
 
(20
06
–2
00
8)
cr
o
ss
-s
ec
tio
na
l e
pi
de
m
io
lo
gi
c 
stu
dy
24
 8
45
 ad
ul
ts 
(ag
ed
 18
–7
4 , 
50
.1
%
 
m
al
e)
ag
e,
 ra
ce
, g
en
de
r, 
ed
uc
at
io
n,
 in
co
m
e,
 
sm
o
ki
ng
, d
rin
ki
ng
, 
ex
er
ci
se
, d
ie
t, 
su
ga
r,
 
fa
m
ily
 h
ist
or
y 
of
 
hy
pe
rte
ns
io
n,
 a
nd
 
di
str
ic
t
B
M
I (
no
rm
al 
w
ei
gh
t n
 
=
 1
4,
 6
46
; 
o
v
er
w
ei
gh
t n
 
=
 8
, 
76
4;
 o
be
se
 n
 
=
 1
, 
43
5)
lo
ng
-te
rm
: a
nn
ua
l 
ar
ith
m
et
ic
 m
ea
n 
o
zo
n
e 
fro
m
 c
en
tra
l 
m
o
n
ito
r w
ith
in
 1
 
km
 o
f p
ar
tic
ip
an
ts’
 
ho
m
es
 in
 1
1 
N
E 
Ch
in
es
e 
ci
tie
s 
m
ea
n
 4
9.
4 
μg
/m
3 
(S
D 
14
.07
, ra
ng
e 
27
–7
1 
μg
/m
3 )
pr
ev
al
en
ce
 o
f 
hy
pe
rte
ns
io
sy
sto
lic
 b
lo
od
 
pr
es
su
re
 (S
BP
)
sy
sto
lic
 b
lo
od
 
pr
es
su
re
 (S
BP
)
di
as
to
lic
 b
lo
od
 
pr
es
su
re
 (D
BP
)
In
te
ra
ct
io
n 
be
tw
ee
n 
w
ei
gh
t s
ta
tu
s 
an
d 
oz
on
e 
ex
po
su
re
 w
as
 o
bs
er
ve
d 
am
o
n
g 
m
al
es
 (p
 
=
 0
.0
41
) a
nd
 al
l 
pa
rti
ci
pa
nt
s (
p 
<
 0
.0
01
), b
u
t n
ot
 
am
o
n
g 
fe
m
al
es
 (p
 
=
 0
.1
77
).
O
dd
s r
at
io
 (O
R)
 in
cre
ase
d w
ith
 
in
cr
ea
sin
g 
w
ei
gh
t c
at
eg
or
y.
 
Fo
r 
a 
22
 
μg
/m
3  
in
cr
ea
se
 in
 o
zo
ne
, a
 lo
w
er
 O
R 
o
f h
yp
er
te
ns
io
n 
am
on
g 
no
rm
al
 
w
ei
gh
t 1
.0
5 
(0.
99
, 1
.13
) w
as
 
re
po
rte
d,
 c
om
pa
re
d 
to
 a
m
on
g 
o
v
er
w
ei
gh
t 1
.1
9 
(1.
10
, 1
.28
), a
nd
 
am
o
n
g 
ob
es
e 
1.
24
 (1
.03
, 1
.49
).
M
al
es
: O
R 
in
cr
ea
se
d 
w
ith
 
in
cr
ea
sin
g 
w
ei
gh
t c
at
eg
or
y.
 
Fo
r 
a 
22
 
μg
/m
3  
in
cr
ea
se
 in
 o
zo
ne
, t
he
 O
R 
of
 
hy
pe
rte
ns
io
n 
am
on
g 
no
rm
al
 w
ei
gh
t 
m
al
es
 w
as
 1
.1
0 
(1.
01
–1
.21
), a
mo
ng
 
o
v
er
w
ei
gh
t 1
.2
4 
(1.
13
–1
.37
), a
nd
 
am
o
n
g 
ob
es
e 
1.
49
 (1
.15
–1
.93
).
Fe
m
al
es
: F
o
r 
a 
22
 μ
g/
m
3  
in
cr
ea
se
 in
 
o
zo
n
e,
 th
e 
O
R 
fo
r h
yp
er
te
ns
io
n 
am
o
n
g 
no
rm
al
 w
ei
gh
t f
em
al
es
 w
as
 
n
o
t s
ig
ni
fic
an
t: 
0.
94
 (0
.85
–1
.04
), 
am
o
n
g 
ov
er
w
ei
gh
t 1
.0
7 
(0.
95
–1
.21
), 
o
r 
am
o
n
g 
ob
es
e 
0.
89
 (0
.67
–1
.18
).
O
zo
ne
 ex
po
su
re
 w
as
 p
os
iti
v
el
y 
as
so
ci
at
ed
 w
ith
 h
ig
he
r s
ys
to
lic
 a
nd
 
di
as
to
lic
 B
P 
an
d 
in
cr
ea
sin
g 
BM
I. 
Th
e 
re
la
tio
ns
hi
p 
w
as
 s
tr
on
ge
r f
or
 
sy
sto
lic
 B
P 
th
an
 d
ia
sto
lic
 B
P,
 
an
d 
am
o
n
g 
al
l p
ar
tic
ip
an
ts 
an
d 
m
al
es
, 
bu
t n
ot
 a
m
on
g 
fe
m
al
es
.
Ch
an
ge
 in
cr
ea
se
d 
w
ith
 in
cr
ea
sin
g 
w
ei
gh
t c
at
eg
or
y.
 
Fo
r 
a 
22
 μ
g/
m
3 
in
cr
ea
se
 in
 o
zo
ne
, a
m
on
g 
no
rm
al
 
w
ei
gh
t, 
SB
P 
in
cr
ea
se
d 
0.
34
 (−
0.1
1, 
0.
79
), a
mo
ng
 ov
er
w
ei
gh
t 1
.7
2 
(1.
08
, 
2.
33
), a
nd
 am
on
g o
be
se 
su
bje
cts
 
3.
46
 (1
.77
, 5
.14
)
M
al
es
: C
ha
ng
e 
in
cr
ea
se
d 
w
ith
 
in
cr
ea
sin
g 
w
ei
gh
t c
at
eg
or
y.
 
Fo
r 
a 
22
 
μg
/m
3  
in
cr
ea
se
 in
 o
zo
ne
, a
m
on
g 
n
o
rm
al
 w
ei
gh
t m
al
es
, S
BP
 in
cr
ea
se
d 
0.
34
 (−
0.1
1, 
0.7
9),
 am
on
g 
o
v
er
w
ei
gh
t 1
.7
2 
(1.
08
, 2
.33
), a
nd
 
am
o
n
g 
ob
es
e 
su
bje
cts
 3.
46
 (1
.77
, 
5.
14
)
Fe
m
al
es
: A
m
on
g 
al
l t
hr
ee
 w
ei
gh
t 
ca
te
go
rie
s, 
SB
P 
ch
an
ge
s w
er
e 
no
t 
sig
ni
fic
an
t.
Fo
r 
a 
22
 μ
g/
m
3  
in
cr
ea
se
 in
 o
zo
ne
, 
am
o
n
g 
no
rm
al
 w
ei
gh
t p
ar
tic
ip
an
ts,
 
Chem Res Toxicol. Author manuscript; available in PMC 2017 August 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Koman and Mancuso Page 23
st
ud
y 
an
d 
lo
ca
tio
n
st
ud
y 
de
sig
n 
an
d 
po
pu
la
tio
n
co
v
a
ri
at
es
o
be
sit
y 
m
ea
su
re
o
zo
n
e 
m
ea
su
re
o
u
tc
om
es
m
a
in
 fi
nd
in
gs
 e
ffe
ct
 e
st
im
at
es
 
(95
%
 C
l)
D
B
P 
in
cr
ea
se
d 
0.
29
 (0
.02
, 0
.56
), 
am
o
n
g 
ov
er
w
ei
gh
t 0
.3
5 
(−
0.0
2, 
0.
72
), a
nd
 am
on
g o
be
se 
su
bje
cts
 
1.
31
 (0
.36
, 2
.27
)
M
al
es
: F
o
r 
a 
22
 μ
g/
m
3  
in
cr
ea
se
 in
 
o
zo
n
e,
 a
m
o
n
g 
no
rm
al
 w
ei
gh
t m
al
es
, 
D
B
P 
in
cr
ea
se
d 
0.
67
 (0
.27
, 1
.07
), 
am
o
n
g 
ov
er
w
ei
gh
t 0
.6
5 
(0.
15
, 1
.14
), 
an
d 
am
on
g 
ob
es
e 
su
bje
cts
 1.
94
 
(0.
64
, 3
.22
)
Fe
m
al
es
: A
m
on
g 
al
l t
hr
ee
 w
ei
gh
t 
ca
te
go
rie
s, 
D
BP
 c
ha
ng
es
 w
er
e 
no
t 
sig
ni
fic
an
t.
Qi
n e
t a
l. 2
01
56
1
cr
o
ss
-s
ec
tio
na
l e
pi
de
m
io
lo
gi
c 
stu
dy
ag
e,
 ra
ce
, g
en
de
r, 
ed
uc
at
io
n,
 in
co
m
e,
 
sm
o
ki
ng
, d
rin
ki
ng
, 
ex
er
ci
se
, d
ie
t, 
su
ga
r,
 
fa
m
ily
 h
ist
or
y 
of
 
hy
pe
rte
ns
io
n 
an
d 
di
str
ic
t
B
M
I (
no
rm
al 
w
ei
gh
t n
 
=
 1
4,
 6
46
, 
o
v
er
w
ei
gh
t n
 
=
 8
, 
76
4,
 o
be
se
 n
 
=
 1
, 
43
5)
lo
ng
-te
rm
: a
nn
ua
l 
ar
ith
m
et
ic
 m
ea
n 
o
zo
n
e 
fro
m
 c
en
tra
l 
m
o
n
ito
r w
ith
in
 1
 
km
 o
f p
ar
tic
ip
an
ts’
 
ho
m
es
 in
 1
1 
N
E 
Ch
in
es
e 
ci
tie
s 
m
ea
n
 4
9.
4 
μg
/m
3 
(S
D 
14
.07
, ra
ng
e 
27
–7
1 
μg
/m
3 )
se
lf-
re
po
rte
d 
st
ro
ke
se
lf-
re
po
rte
d 
ca
rd
io
v
as
cu
la
r 
di
se
as
e
B
ei
ng
 o
v
er
w
ei
gh
t o
r o
be
se
 m
od
ifi
ed
 
th
e 
ef
fe
ct
s o
f o
zo
ne
 o
n 
se
lf-
re
po
rte
d 
st
ro
ke
. 
Ef
fe
ct
 e
sti
m
at
es
 w
er
e 
st
ro
ng
er
 a
m
on
g 
ob
es
e 
co
m
pa
re
d 
to
 
n
o
rm
al
 a
nd
 o
v
er
w
ei
gh
t c
at
eg
or
ie
s 
(in
ter
ac
tio
n p
 
=
 0
.0
02
). W
he
n 
st
ra
tif
ie
d 
by
 g
en
de
r, 
in
te
ra
ct
io
n 
be
tw
ee
n 
oz
on
e 
an
d 
BM
I c
at
eg
or
y 
w
as
 s
ta
tis
tic
al
ly
 si
gn
ifi
ca
nt
 a
m
on
g 
w
o
m
en
 (p
 
=
 0
.0
46
) b
u
t n
ot
 a
m
on
g 
m
en
 (p
 
=
 0
.5
01
).
33
 c
om
m
un
iti
es
 in
 th
re
e 
n
o
rt
he
as
te
rn
 C
hi
ne
se
 c
iti
es
 
(20
06
–2
00
8)
24
 8
45
 ad
ul
ts 
(ag
ed
 18
-74
; 
50
.1
%
 
m
al
e)
Fo
r 
a 
22
 μ
g/
m
3  
in
cr
ea
se
 in
 o
zo
ne
; 
a 
hi
gh
er
 O
R 
of
 st
ro
ke
 a
m
o
n
g 
no
rm
al
 
w
ei
gh
t 0
.9
8 
(0.
82
, 1
.18
), c
om
pa
red
 
to
 a
m
on
g 
ov
er
w
ei
gh
t 1
.2
9 
(1.
05
, 
1.
59
), a
nd
 am
on
g o
be
se 
1.4
7 (
0.8
3, 
2.
59
).
M
al
es
: O
R 
w
er
e 
no
t d
iff
er
en
t b
y 
bi
na
ry
 w
ei
gh
t c
at
eg
or
y.
 
Fo
r 
a 
22
 
μg
/m
3  
in
cr
ea
se
 in
 o
zo
ne
, t
he
 O
R 
of
 
st
ro
ke
 a
m
o
n
g 
no
rm
al
 w
ei
gh
t m
al
es
 
w
as
 1
.1
5 
(0.
93
–1
.44
), a
mo
ng
 
o
v
er
w
ei
gh
t/o
be
se
 1
.3
0 
(0.
99
–1
.77
).
Fe
m
al
es
: F
o
r 
a 
22
 μ
g/
m
3  
in
cr
ea
se
 in
 
o
zo
n
e,
 th
e 
O
R 
fo
r s
tro
ke
 a
m
o
n
g 
n
o
rm
al
 w
ei
gh
t f
em
al
es
 w
as
 n
o
t 
sig
ni
fic
an
t: 
0.
88
 (0
.63
–1
.21
) b
u
t w
as
 
sig
ni
fic
an
t a
m
on
g 
ov
er
w
ei
gh
t/o
be
se
 
1.
36
 (1
.02
–1
.80
).
B
ei
ng
 o
v
er
w
ei
gh
t o
r o
be
se
 m
od
ifi
ed
 
th
e 
ef
fe
ct
s o
f o
zo
ne
 o
n 
se
lf-
re
po
rte
d 
CV
D
. E
ffe
ct
 e
sti
m
at
es
 w
er
e 
str
on
ge
r 
am
o
n
g 
ob
es
e 
co
m
pa
re
d 
to
 n
or
m
al
 
an
d 
ov
er
w
ei
gh
t c
at
eg
or
ie
s b
u
t d
id
 
n
o
t r
ea
ch
 st
at
ist
ic
al
 si
gn
ifi
ca
nc
e 
at
 
95
%
 co
nf
id
en
ce
 le
v
el
 (i
nte
rac
tio
n p
 
=
 0
.1
21
).
Fo
r 
a 
22
 μ
g/
m
3  
in
cr
ea
se
 in
 o
zo
ne
, a
 
lo
w
er
 O
R 
of
 h
yp
er
te
ns
io
n 
am
on
g 
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st
ud
y 
an
d 
lo
ca
tio
n
st
ud
y 
de
sig
n 
an
d 
po
pu
la
tio
n
co
v
a
ri
at
es
o
be
sit
y 
m
ea
su
re
o
zo
n
e 
m
ea
su
re
o
u
tc
om
es
m
a
in
 fi
nd
in
gs
 e
ffe
ct
 e
st
im
at
es
 
(95
%
 C
l)
n
o
rm
al
 w
ei
gh
t 1
.0
8 
(0.
8, 
1.1
35
) a
nd
 
am
o
n
g 
ov
er
w
ei
gh
t 1
.0
8 
(0.
86
, 1
.35
), 
co
m
pa
re
d 
to
 a
m
on
g 
ob
es
e 
1.
56
 
(1.
02
, 2
.39
).
W
he
n 
str
at
ifi
ed
 b
y 
ge
nd
er
,
 
a 
tw
o
-
ca
te
go
ry
 w
ei
gh
t e
ffe
ct
 m
od
ifi
ca
tio
n 
w
as
 n
o
t s
ig
ni
fic
an
t
a A
bb
re
v
ia
tio
ns
: a
irw
ay
 h
yp
er
re
sp
on
siv
en
es
s 
(A
HR
), b
od
y m
ass
 in
de
x
 (B
M
I);
 ca
rdi
ov
as
cu
la
r d
ise
as
e 
(C
VD
); 
dia
sto
lic
 bl
oo
d p
res
su
re 
(D
BP
); 
eo
sin
op
hil
s (
Eo
s);
 fo
rce
d e
x
pi
ra
to
ry
 v
o
lu
m
e 
in
 o
ne
 se
co
nd
 
(F
EV
1)
; f
orc
ed
 vi
tal
 ca
pa
cit
y (
FV
C)
; f
orc
ed
 ex
pi
ra
to
ry
 fl
ow
 a
t 2
5–
75
%
 o
f F
V
C 
(F
EF
25
−7
5%
); 
int
erl
eu
kin
 (I
L)
; p
oly
mo
rph
on
uc
lea
r (
PM
N)
; o
dd
s r
ati
o (
OR
); 
sy
sto
lic
 bl
oo
d p
res
su
re 
(S
BP
); 
tum
or 
ne
cro
sis
 
fa
ct
or
 a
lp
ha
 (T
NF
-α)
; U
.S.
 E
nv
iro
nm
en
ta
l P
ro
te
ct
io
n 
A
ge
nc
y 
(E
PA
); 
μg
/m
3  
m
ic
ro
gr
am
s p
er
 c
ub
ic
 m
et
er
.
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